Genentech goes beyond pharmaceutical manufacturing in its work with members of the SMA community. Michael Dunn explains

For any organization, one ill-timed tweet can create enormous backlash.

CEO and Founder of EnteroBiotix James McIllroy shares the wonders of manipulating our microbial passengers.

A growing number of deaths linked to pediatric medicines prompts the WHO to investigate “unacceptable” levels of APIs.

Regeneron Pharmaceuticals’ Israel Lowy explains how a positive CHMP opinion can become good news for cancer patients

How critical anti-cancer drugs can be sustainably developed from genetically engineered baker’s yeast.

Historic challenges in ADC Development have not thwarted some players

AMR remains a pressing issue, but hydroquinine has yielded some interesting effects on clinically important bacteria